Articles

The Obama Administration has made global food security a top priority in which American agriculture must play a key role.

Biotechnology allows farmers to grow more food on less land using farming practices that are environmentally sustainable. Through biotechnology:

Seeds yield more per acre, plants naturally resist specific insect pests and diseases, and farming techniques improve soil conservation.

Enhanced Sustainability and Reduced Environmental Footprint

Agricultural biotechnology has helped enable large shifts in agronomic practices that have led to significant and widespread environmental benefits.

No-till agriculture, in limited use prior to 1996, has been widely adopted due to the superior weed control from biotech crops that are able to tolerate herbicides with low environmental impacts. This has led to improved soil health and water retention, reduced runoff, and reduced greenhouse gas emissions from reduced on-farm energy use.

Biotechnology provides new tools for improving human health and animal health and welfare and increasing livestock productivity. Biotechnology improves the food we eat - meat, milk and eggs. Biotechnology can improve an animal’s impact on the environment. And biotechnology enhances ability to detect, treat and prevent diseases.

From August 16 to August 22, 2010, Hart Research Associates conducted a nationwide survey among 1,000 adults about attitudes toward the entities involved in the oversight of new scientific and technological advances, awareness of nanotechnology, and awareness of and attitudes toward synthetic biology and two potential applications of the science.

Research institutions, companies and producer groups engaged in the growing field of animal biotechnology place animal well-being as a top priority. The humane care and use of animals in genomics, cloning and transgenics is guided by rigorous regulatory review and, in some instances, third party review.

For decades, animals have been used to produce pharmaceuticals for the benefit of human health. Biologics such as antibodies used for anti-venoms and transplant organ rejection, heparin (an anti-blood clotting protein) and many others have been obtained from horses, pigs, rabbits and other species.

A genetically engineered (GE) animal is one which has had a deliberate modification made to its genome. Genetic engineering allows scientists to precisely transfer beneficial genes from one species to another. GE animals provide solutions to transform public health through biomedical, environmental, and food applications.

A genetically engineered (GE) animal is one which has had a deliberate modification made to its genome. Genetic engineering allows scientists to precisely transfer beneficial genes from one species to another.

Oils produced by algae hold the potential for replacing fossil resources in many products. In fact, according to recent research, much of the petroleum and coal we drill for and use today was originally produced thousands of years ago by a species of green algae.

The purpose of this survey was to examine technology transfer and licensing practices by biotechnology companies and determine its importance to the industry.

This backgrounder emphasizes the importance of strengthening the SBIR program to support bringing scientific innovation to the public.

The summary explains the criteria for investment companies, the process by which investment companies would apply and the manner in which the equity financing provided by the SBA could used.

“Volunteers” (a plant that grows on its own, rather than being deliberately planted by a human) can happen because seeds can be transported by the wind, spilled from vehicles transporting grain or seed or dropped by birds.

Over the past few years, fuel ethanol production from grains has become a major business of national importance, resulting in increased availability of distillers’ grains (DG) for use in animal feed. A natural question is whether the processing aids used in ethanol manufacture are safe for the animals fed the DG co-product.

The Department of Energy's Assistant Secretary Cathy Zoi announced funding of $24 million for three research groups addressing key hurdles in commercialization of algae at the 2010 World Congress.

One of the most promising uses of algae is as renewable raw material for biofuels.

The U.S. bioscience industry continued to score employment gains through 2008 - the first year of the recent economic downturn, according to a study released today by Battelle and the Biotechnology Industry Organization (BIO).

Learn about the potential for using algae in a biorefinery to produce biofuels, renewable chemicals, and food ingredients.

On April 8, 2004, Genentech, Inc. filed a Citizen Petition with the Food and Drug Administration (FDA), requesting that the agency refrain from (1) publishing a draft guidance document setting forth standards for so-called follow-on or "generic" biotechnology-derived products, and (2) approving an application filed under section 505(b)(2) of the Food, Drug and Cosmetic Act (FDCA) with respect to a biotechnology product that relies, directly or indirectly, on trade secret and confidential commercial data and information of an innovator.

The European Medicines Agency (EMEA), the European equivalent to the Food and Drug Administration (FDA), has implemented an approval scheme that specifically distinguishes between biosimilars (follow-on biologics) and generic drugs.

Agricultural biotechnology is an advanced technology that allows plant breeders to make precise genetic changes to impart beneficial traits to the crop plants we rely on for food and fiber.